EL En S p A : Conference call - Q12023- Financial results - May 16

COMPANY PRESENTATION

CONFERENCE CALL

Q1 2023 Financial results

May 16th, 2023

1

DISCLAIMER

Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward- looking statements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward- looking statements. The Company undertakes no obligation about the contents nor to update the forward- looking statements to reflect events or circumstances that may arise after the date hereof.

2

Income Statement - Q1 2023

Euro '000	31/03/22	%	31/03/23	%	Var. %
	unaudited		unaudited
Medical	87.179	60,4%	96.812	60,0%	11,1%
Industrial	57.205	39,6%	64.543	40,0%	12,8%
Revenues	144.384	100,0%	161.355	100,0%	11,8%
Gross margin	55.013	38,1%	61.123	37,9%	11,1%
Operating Expenses	11.841	8,2%	14.066	8,7%	18,8%
Staff espenses	23.097	16,0%	26.123	16,2%	13,1%
EBITDA	20.075	13,9%	20.934	13,0%	4,3%
Depr., amort., accruals	2.996	2,1%	3.902	2,4%	30,2%
EBIT	17.079	11,8%	17.032	10,6%	-0,3%
Net financ.income(charges)	473	0,3%	(459)	-0,3%
Other income (expense) net	(7)	0,0%	36	0,0%
EBT	17.545	12,2%	16.608	10,3%	-5,3%
	31/12/22		31/03/23
			unaudited
Net financial position	88.546		56.702

3

Cash Flow

26 mln

16 mln

4

Revenue breakdown by business

+9%

Medical: +11%

+33%

+1%

+6%

+9%

in Euro million

+52%

	+17%
-2%	Industrial: +13%

5